Glucagon Like Peptide-1 Receptor Agonists and the Risk of Skin Cancer Among Patients with Type 2 Diabetes: Population-Based Cohort Study.

Richeek PradhanOriana H Y YuRobert W PlattLaurent Azoulay

Published in: Diabetic medicine : a journal of the British Diabetic Association (2023)

In this population-based cohort study, GLP-1 RAs were not associated with an increased risk of melanoma or nonmelanoma skin cancer, compared with sulfonylureas.

Keyphrases

skin cancer
wild type